多波长激光联合曲安奈德球后注射治疗非增殖性糖尿病性视网膜病变黄斑水肿的临床观察
The Observation of Clinical Results for Macular Edema of Nonproliferative Diabetic Retinopathy by Multiwavelength Laser Combined with Retrobulbar Injection of Triamcinolone Acetonide
摘要: 目的：评价多波长氪黄激光联合曲安奈德球后注射治疗非增殖性糖尿病性视网膜病变黄斑水肿的临床效果。方法：收集确诊为非增殖性糖尿病性视网膜病变黄斑水肿的患者，经同质化筛选后，确定共93例(136眼)有效病例，进行随机分组：治疗组47例(72眼)使用多波长氪黄激光黄斑光凝联合曲安奈德球后注射治疗；对照组39例(64眼)仅多波长氪黄激光黄斑光凝。治疗后进行随访，观察比较患者最佳矫正视力(Best corrected visual acuity, BCVA)和黄斑中心凹厚度(Determination of macular retinal thickness, DMT)。结果：两组组内比较，治疗3个月后，两组的最佳矫正视力(BCVA)均比治疗前提高明显(P < 0.05)，差异具有统计学意义，黄斑中心凹厚度(DMT)明显小于治疗前(P < 0.05)，差异具有统计学意义；两组组间比较，最佳矫正视力差异有显著性(P < 0.05)，黄斑中心凹厚度在治疗6个月，无明显差异(P > 0.05)。结论：多波长氪黄激光联合曲安奈德球后注射治疗非增殖性糖尿病性视网膜病变黄斑水肿的临床效果显著。
Abstract: Objective: To evaluate the clinical effect of multi wavelength krypton yellow laser combined with retrobulbar injection of triamcinolone acetonide in the treatment of macular edema in non-prolife- rative diabetic retinopathy. Methods: 93 cases of 136 eyes macular edema in patients with non-pro- liferative diabetic retinopathy, 72 eyes of which treated by multiwavelength laser combined with retrobulbar injection of triamcinolone acetonide, another 64 eyes treated by multi-wavelength laser, detectting and comparing the two groups of patients before and after treat, include best corrected visual acuity and determination of macular retinal thickness. Results: The best corrected visual acuity increased more significantly compared with preoperative (P < 0.05) in both group after treat. The determination of macular retinal thickness decreased more significantly compared with preoperative (P < 0.05). in both group after treated. The best corrected visual acuity had significient difference compared with two group after treat (P < 0.05). The determination of macular retinal thickness had no significient difference compared with two group six months after treat (P > 0.05). Conclusion: The clinical effect of multi wavelength krypton yellow laser combined with retrobulbar injection of triamcinolone acetonide in the treatment of macular edema by nonproliferative diabetic retinopathy is significant.
文章引用：宋学英, 齐绍文, 胡长娥, 杨惠春. 多波长激光联合曲安奈德球后注射治疗非增殖性糖尿病性视网膜病变黄斑水肿的临床观察[J]. 眼科学, 2020, 9(3): 191-196. https://doi.org/10.12677/HJO.2020.93025

参考文献

[1] Yang, W., Lu, J., Weng, J., et al. (2010) Prevalence of Diabetes among Men and Women in China. The New England Journal of Medicine, 362, 1090-1091.
[Google Scholar] [CrossRef] 
[2] Klein, B.E. (2007) Overview of Epidemiologic Studies of Diabetic Retinopathy. Ophthalmic Epidemiology, 14, 179-183.
[Google Scholar] [CrossRef] [PubMed]
[3] 张大卫, 张蕊, 杨敏, 等. 球周注射曲安奈德联合全视网膜光凝治疗糖尿病黄斑水肿疗效观察[J]. 疑难病杂志, 2016, 15(12): 1263-1267.
[4] Alvi, R., Memon, M.S., Shera, S., et al. (2016) Visual Outcome of Laser Treatment in Diabetic Macular Edema: Study from an Urban Diabetes Care Center. Pakistan Journal of Medical Sciences, 32, 1229-1233.
[Google Scholar] [CrossRef] [PubMed]
[5] 徐静娴, 张贤亮, 石壮, 等. 糖尿病视网膜病变激光光凝术后黄斑区脉络膜厚度变化的观察[J]. 中国实用眼科杂志, 2015, 33(6): 598-602.
[6] 梁丽, 单明华, 徐斌, 等. 传统格栅样激光与577nm黄色微脉冲激光光凝治疗视网膜静脉阻塞并发黄斑水肿的疗效比[J]. 河北医科大学学报, 2015, 33(3): 356-358.
[7] Bressler, N.M., Beck, R.W., Ferris, F.L., et al. (2011) Panretinal Photocoagulation for Proliferative Diabetic Retinopathy. The New England Journal of Medicine, 16, 2234-237.
[Google Scholar] [CrossRef] 
[8] 张磊, 刘大川, 吴航. 糖尿病视网膜病变患眼激光光凝治疗前后黄斑区脉络膜厚度的增强深部成像技术测量[J]. 中华眼底病杂志, 2014, 30(6): 562-565.
[9] 卢百阳, 武志峰, 孙松, 等. 全视网膜光凝对糖尿病视网膜病变神经纤维层及黄斑厚度的影响[J]. 山东医药, 2010, 50(32): 12-15.
[10] 董秀清, 冯松福, 柯晓云. 应用光学相干断层扫描量化评估糖尿病黄斑水肿的临床研究[J]. 眼科新进展, 2017, 37(2): 133-136.
[11] 刘祥杰. 糖尿病性视网膜病变激光治疗时机[J]. 临床医学, 2015(3): 95-96.
[12] Avery, R.L. and Gordon, G.M. (2016) Systemic Safety of Prolonged Monthly Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema: A Systematic Review and Meta-Analysis. JAMA Ophthalmology, 134, 21-29.
[Google Scholar] [CrossRef] [PubMed]
[13] 齐慧君, 黎晓新. 糖尿病性黄斑水肿的激光治疗[J]. 眼科, 2005, 14(4): 234-236.
[14] 刘新, 邹吉新, 张立军, 等. PASCAL激光一次性全视网膜光凝治疗增殖性糖尿病视网膜病变[J]. 国际眼科杂志, 2016, 16(4): 712-715.
[15] Hu, Y., Zhang, T., Wang, K., et al. (2015) Changes in Choroidal Thickness after Panretinal Photocoagulation in Patients with Type 2 Diabetes. Retina, 35, 695-703.
[Google Scholar] [CrossRef] 
[16] Nguyen, Q.D., Brown, D.M., Marcus, D.M., et al. (2012) Ranibizumab for Diabetic Macular Edema: Results from 2 Phase III Randomized Trials: RISE and RIDE. Ophthalmology, 119, 789-801.
[Google Scholar] [CrossRef] [PubMed]
[17] Massin, P., Audren, F., Haouchine, B., Erginay, A., Bergmann, J.F., Benosman, R., et al. (2004) Intravitreal Triamcinolone Acetonide for Diabetic Diffuse Macular Edema Preliminary Results of a Prospective Controlled Trial. Ophthalmology, 111, 218-224.
[Google Scholar] [CrossRef] [PubMed]
[18] Jonas, J.B., Kreisig, I. and Sotker, A. (2003) Intravitreal Injection of Triamcinolone for Diffuse Diabetic Macular Edema. Archives of Ophthalmology, 121, 57-61.
[Google Scholar] [CrossRef] 
[19] Bonini-Filho, M.A., Jorge, R., Barbosa, J.C., et al. (2005) Intravitreal Injection versus Sub-Tenon’s Infusion of Triamcinolone Ace-Tonide for Refractory Diabetic Macular Edema: A Randomized Clinical Trial. Investigative Ophthalmology & Visual Science, 46, 3845-38499.
[Google Scholar] [CrossRef] [PubMed]
[20] 潘竹娟, 张志辉, 樊飞红, 等. 全视网膜光凝联合雷珠单抗与曲安奈德治疗糖尿病黄斑水肿的疗效及费用比较[J]. 国际眼科杂志, 2018, 18(4): 682-685.
[21] 翁宏武, 王柯鳗, 马海智, 等. 玻璃体内注射曲安奈德联合黄斑部格栅样光凝治疗弥漫性糖尿病性黄斑水肿[J]. 眼科新进展, 2016, 36(11): 1050-1053.
[22] 褚梦琪. 视网膜静脉阻塞继发黄斑水肿的最新治疗进展[J]. 中华实验眼科杂志, 2018, 36(1): 65.
[23] 谢碧华, 何宇, 辛梅, 等. 曲安奈德与雷珠单抗辅助治疗弥漫性糖尿病性黄斑水肿的疗效比较[J]. 国际眼科杂志, 2018, 18(6): 1089-1092.
[24] Pak, K.Y., Choi, B.S., Park, S.W., et al. (2017) Comparison of Vitrectomized with Nonvitrectomized Eyes after Subtenon Injection of Triamcinolone Acetonide to Treat Diabetic Macular Edema: Retrospective Comparative Analysis of an Interventional Case Series. Indian Journal of Ophthalmology, 65, 488-492.
[Google Scholar] [CrossRef] 

为你推荐